These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11134541)

  • 1. In vitro human tissue models in risk assessment: report of a consensus-building workshop.
    MacGregor JT; Collins JM; Sugiyama Y; Tyson CA; Dean J; Smith L; Andersen M; Curren RD; Houston JB; Kadlubar FF; Kedderis GL; Krishnan K; Li AP; Parchment RE; Thummel K; Tomaszewski JE; Ulrich R; Vickers AE; Wrighton SA
    Toxicol Sci; 2001 Jan; 59(1):17-36. PubMed ID: 11134541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biokinetic and toxicodynamic modelling and its role in toxicological research and risk assessment.
    Blaauboer BJ
    Altern Lab Anim; 2003; 31(3):277-81. PubMed ID: 15612871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicokinetic modeling and its applications in chemical risk assessment.
    Andersen ME
    Toxicol Lett; 2003 Feb; 138(1-2):9-27. PubMed ID: 12559690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integration of data on physico-chemical properties, in vitro-derived toxicity data and physiologically based kinetic and dynamic as modelling a tool in hazard and risk assessment. A commentary.
    Blaauboer BJ
    Toxicol Lett; 2003 Feb; 138(1-2):161-71. PubMed ID: 12559700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormesis and toxicological risk assessment.
    Rodricks JV
    Toxicol Sci; 2003 Feb; 71(2):134-6. PubMed ID: 12563098
    [No Abstract]   [Full Text] [Related]  

  • 6. Panel discussion: application of physiological-toxicokinetic modelling.
    Dybing E
    Toxicol Lett; 2003 Feb; 138(1-2):173-8. PubMed ID: 12559701
    [No Abstract]   [Full Text] [Related]  

  • 7. Physiologically based pharmacokinetic (PB-PK) models in the study of the disposition and biological effects of xenobiotics and drugs.
    Andersen ME
    Toxicol Lett; 1995 Dec; 82-83():341-8. PubMed ID: 8597075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Workshop overview: use of genomic data in risk assessment.
    Cunningham ML; Bogdanffy MS; Zacharewski TR; Hines RN
    Toxicol Sci; 2003 Jun; 73(2):209-15. PubMed ID: 12700425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human placenta: a human organ for developmental toxicology research and biomonitoring.
    Myllynen P; Pasanen M; Pelkonen O
    Placenta; 2005 May; 26(5):361-71. PubMed ID: 15850640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.
    Hays SM; Aylward LL; LaKind JS; Bartels MJ; Barton HA; Boogaard PJ; Brunk C; DiZio S; Dourson M; Goldstein DA; Lipscomb J; Kilpatrick ME; Krewski D; Krishnan K; Nordberg M; Okino M; Tan YM; Viau C; Yager JW;
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S4-15. PubMed ID: 18583008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated approaches for the analysis of toxicologic interactions of chemical mixtures.
    el-Masri HA; Reardon KF; Yang RS
    Crit Rev Toxicol; 1997 Mar; 27(2):175-97. PubMed ID: 9099518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying machine learning techniques for ADME-Tox prediction: a review.
    Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver cell models in in vitro toxicology.
    Guillouzo A
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):511-32. PubMed ID: 9599700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Options for incorporating children's inhaled dose into human health risk assessment.
    Ginsberg G; Foos B; Dzubow RB; Firestone M
    Inhal Toxicol; 2010 Jul; 22(8):627-47. PubMed ID: 20540622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems Toxicology: The Future of Risk Assessment.
    Sauer JM; Hartung T; Leist M; Knudsen TB; Hoeng J; Hayes AW
    Int J Toxicol; 2015; 34(4):346-8. PubMed ID: 25804424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction.
    Al Sharif M; Alov P; Vitcheva V; Diukendjieva A; Mori M; Botta B; Tsakovska I; Pajeva I
    Toxicol Appl Pharmacol; 2017 Dec; 337():45-66. PubMed ID: 29056366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systems analysis of toxico-kinetic laws based on the chamber modeling in the light of the tasks of hygienic toxicology].
    Katsnel'son BA; Bezel' VS; Konysheva LK
    Gig Sanit; 1992; (5-6):9-13. PubMed ID: 1398195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.